From the Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University (I.O., K.D., G.H., J.Z.).
Institute of Translational Medicine (X.H., H.X.), Nanchang University, China.
Circ Res. 2019 Apr 26;124(9):1309-1322. doi: 10.1161/CIRCRESAHA.118.314187.
TEAD (TEA domain transcription factor) 1-a major effector of the Hippo signaling pathway-acts as an oncoprotein in a variety of tumors. However, the function of TEAD1 in vascular smooth muscle cells (VSMCs) remains unclear.
To assess the role of TEAD1 in vascular injury-induced smooth muscle proliferation and delineate the mechanisms underlying its action.
We found that TEAD1 expression is enhanced in mouse femoral artery after wire injury and correlates with the activation of mTORC1 (mechanistic target of rapamycin complex 1) signaling in vivo. Using an inducible smooth muscle-specific Tead1 KO (knockout) mouse model, we found that specific deletion of Tead1 in adult VSMCs is sufficient to attenuate arterial injury-induced neointima formation due to inhibition of mTORC1 activation and VSMC proliferation. Furthermore, we found that TEAD1 plays a unique role in VSMCs, where it not only downregulates VSMC differentiation markers but also activates mTORC1 signaling, leading to enhanced VSMC proliferation. Using whole-transcriptome sequencing analysis, we identified Slc1a5 (solute carrier family 1 member 5)-a key glutamine transporter-as a novel TEAD1 target gene. SLC1A5 overexpression mimicked TEAD1 in promoting mTORC1 activation and VSMC proliferation. Moreover, depletion of SLC1A5 by silencing RNA or blocking SLC1A5-mediated glutamine uptake attenuated TEAD1-dependent mTORC1 activation and VSMC proliferation.
Our study unravels a novel mechanism by which TEAD1 promotes VSMC proliferation via transcriptional induction of SLC1A5, thereby activating mTORC1 signaling and promoting neointima formation.
TEAD(TEA 结构域转录因子)1 是 Hippo 信号通路的主要效应因子,在多种肿瘤中作为癌蛋白发挥作用。然而,TEAD1 在血管平滑肌细胞(VSMCs)中的功能尚不清楚。
评估 TEAD1 在血管损伤诱导的平滑肌增殖中的作用,并阐明其作用的机制。
我们发现,TEAD1 的表达在小鼠股动脉的钢丝损伤后增强,并且与体内 mTORC1(雷帕霉素靶蛋白复合物 1)信号的激活相关。使用可诱导的平滑肌特异性 Tead1 KO(敲除)小鼠模型,我们发现,在成年 VSMCs 中特异性缺失 Tead1 足以抑制 mTORC1 激活和 VSMC 增殖,从而减轻动脉损伤诱导的新生内膜形成。此外,我们发现 TEAD1 在 VSMCs 中发挥独特的作用,不仅下调 VSMC 分化标志物,而且激活 mTORC1 信号,导致 VSMC 增殖增强。通过全转录组测序分析,我们鉴定出 Slc1a5(溶质载体家族 1 成员 5)-一种关键的谷氨酰胺转运体-作为新的 TEAD1 靶基因。SLC1A5 的过表达模拟了 TEAD1 促进 mTORC1 激活和 VSMC 增殖的作用。此外,通过沉默 RNA 或阻断 SLC1A5 介导的谷氨酰胺摄取来耗尽 SLC1A5,可减弱 TEAD1 依赖性 mTORC1 激活和 VSMC 增殖。
我们的研究揭示了一种新的机制,即 TEAD1 通过转录诱导 SLC1A5 促进 VSMC 增殖,从而激活 mTORC1 信号并促进新生内膜形成。